ALK and metastatic malignant neoplasm in the lymph nodes: In addition, our previous report revealed a significantly higher incidence of occult lymph node metastases in ALK-positive NSCLC, which makes these patients good candidates for adjuvant chemotherapy according to the clinical guidelines [14].